business π¬ Q-Line Biotech IPO: What You Need to Know
Q-Line Biotech is launching its maiden book building IPO for 6,253,200 equity shares at a price band of Rs. 326 - Rs. 343. The company, which develops and manufactures diagnostic reagents, will open for subscription on May 21, 2026, and close on May 25, 2026. Financially, it showed top-line growth but had an inconsistent bottom line, reporting Rs. 28.13 cr net profit for FY25. The IPO aims to raise Rs. 214.48 cr, with funds designated for working capital and debt repayment. Informed investors might consider parking moderate funds for the long term.